Evidence map›Paper›PMID 32051408›Full record

ArticleNature communications2020

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface.

C Coral Domínguez-Medina, Marisol Pérez-Toledo, Anna E Schager, Jennifer L Marshall, Charlotte N Cook, Saeeda Bobat, Hyea Hwang, Byeong Jae Chun, Erin Logan, Jack A Bryant and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Applied and environmental microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Multivalent vaccines for invasiveInfection and immunity · 2026
    Review
  9. Article
  10. Deletion ofFrontiers in microbiology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Proximity biotinylation at the host-bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Vaccines · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 4 countries.

C Coral Domínguez-Medina *Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Marisol Pérez-Toledo *Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.ORCID http://orcid.org/0000-0002-5734-255X
Anna E SchagerInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Jennifer L MarshallInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Charlotte N CookInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Saeeda BobatInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Hyea HwangSchool of Materials Science and Engineering, Georgia Institute of Technology, Atlanta GA, 30332, USA.
Byeong Jae ChunSchool of Materials Science and Engineering, Georgia Institute of Technology, Atlanta GA, 30332, USA.ORCID http://orcid.org/0000-0002-6095-3482
Erin LoganInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Anzio Road, Cape Town, Western Cape, 7925, South Africa.
Jack A BryantInstitute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, UK.
Will M ChannellInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Faye C MorrisInstitute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, UK.
Sian E JossiInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Areej AlshayeaInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Amanda E RossiterInstitute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, UK.
Paul A BarrowSchool of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington, Leicestershire, LE12 5RD, UK.
William G HorsnellInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Anzio Road, Cape Town, Western Cape, 7925, South Africa.
Calman A MacLennanJenner Institute, Nuffield Department of Medicine, Old Road Campus Research Building, Roosevelt Drive, University of Oxford, Oxford, OX3 7DQ, UK.
Ian R HendersonInstitute of Microbiology and Infection, University of Birmingham, Birmingham, B15 2TT, UK.
Jeremy H LakeyInstitute for Cell and Molecular Biosciences, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK.
James C GumbartSchool of Physics, Georgia Institute of Technology, Atlanta, GA, 30332, USA.
Constantino López-MacíasMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI" Mexican Institute for Social Security, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-0530-492X
Vassiliy N BavroSchool of Life Sciences, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK. v.bavro@essex.ac.uk.ORCID http://orcid.org/0000-0003-2330-8924
Adam F CunninghamInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK. a.f.cunningham@bham.ac.uk.
University of Birmingham · GBGeorgia Institute of Technology · USMexican Social Security Institute · MXUniversity of Cape Town · ZANewcastle University · GBUniversity of Essex · GBUniversity of Nottingham · GBUniversity of Oxford · GB

Funding

Dynamic characterization of outer-membrane-protein biogenesis by the BAM and TAM complexesR01GM123169 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI GUMBART, JAMES C. · 2017 to 2021
$1.4M
Biotechnology and Biological Sciences Research Council BB/L009986/1Medical Research Council MR/N023706/1Medical Research Council MR/P008852/1Medical Research Council MR/R005974/1NIGMS NIH HHS R01 GM123169Wellcome TrustWellcome Trust 108372/A/15/Z
6 · The paper itself

Abstract

Lipopolysaccharide (LPS) O-antigen (O-Ag) is known to limit antibody binding to surface antigens, although the relationship between antibody, O-Ag and other outer-membrane antigens is poorly understood. Here we report, immunization with the trimeric porin OmpD from Salmonella Typhimurium (STmOmpD) protects against infection. Atomistic molecular dynamics simulations indicate this is because OmpD trimers generate footprints within the O-Ag layer sufficiently sized for a single IgG Fab to access. While STmOmpD differs from its orthologue in S. Enteritidis (SEn) by a single amino-acid residue, immunization with STmOmpD confers minimal protection to SEn. This is due to the OmpD-O-Ag interplay restricting IgG binding, with the pairing of OmpD with its native O-Ag being essential for optimal protection after immunization. Thus, both the chemical and physical structure of O-Ag are key for the presentation of specific epitopes within proteinaceous surface-antigens. This enhances combinatorial antigenic diversity in Gram-negative bacteria, while reducing associated fitness costs.

Indexed as

ImmunizationAnimalsAntibodies, BacterialAntibody FormationAntibody SpecificityAntigens, BacterialBacterial Outer Membrane ProteinsCross ProtectionDisease Models, AnimalEpitopesImmunoglobulin GMiceModels, MolecularO AntigensPorinsProtein ConformationAntibodies, BacterialAntigens, BacterialBacterial Outer Membrane ProteinsEpitopesImmunoglobulin GO AntigensOmpD protein, Salmonella typhimuriumPorins

Identifiers

PMID32051408
PMCPMC7015928
OpenAlexW3006578555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.